Financials Legend Biotech Corporation

Equities

LEGN

US52490G1022

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 16:00:00 2026-03-10 EDT			5-day change	1st Jan Change
19.56 ^USD	+2.19%		+9.52%	-10.03%

03-10	Legend Biotech Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
03-10	Legend Biotech Corporation, Q4 2025 Earnings Call, Mar 10, 2026

Projected Income Statement: Legend Biotech Corporation

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net sales ¹	75.68	89.79	117	285.1	627.2	1,029	1,439	1,796
Change	-	18.65%	30.31%	143.7%	119.97%	64.04%	39.88%	24.79%
EBITDA ¹	-220.8	-360.6	-443.2	-392.1	-113.2	-107.5	165.1	347.6
Change	-	-63.35%	-22.9%	11.52%	71.14%	5%	253.61%	110.51%
EBIT ¹	-229.2	-373	-455.8	-412.6	-136.5	-136.5	80.29	370
Change	-	-62.75%	-22.19%	9.49%	66.91%	0.01%	158.82%	360.79%
Interest Paid ¹	-4.209	-0.9	-10.8	-21.79	-21.62	-19.75	-17.33	-17.33
Earnings before Tax (EBT) ¹	-307.6	-386.2	-445.7	-520.1	-158.1	-282.6	34.18	333
Change	-	-25.55%	-15.41%	-16.69%	69.6%	-78.71%	112.09%	874.52%
Net income ¹	-303.5	-386.2	-446.3	-518.3	-177	-296.8	34.34	299.3
Change	-	-27.26%	-15.57%	-16.11%	65.84%	-67.66%	111.57%	771.61%
Announcement Date	3/18/21	3/18/22	3/30/23	3/11/24	3/11/25	3/10/26	-	-

¹USD in Million

Estimates

Fiscal Period: December	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3
Net sales ¹	40.78	13.68	20.23	16.88	39	40.83	11.97	-	36.34	73.33	96.01	79.46	93.99	186.5	160.2	186.5	195.1	255.1	272.3	306.3	306.1	337	365.2	396	431.4	456.4	481.4
Change	-	-66.45%	47.88%	-16.56%	130.99%	4.7%	-70.68%	-	-	101.81%	30.93%	-17.24%	18.28%	98.45%	-14.11%	16.43%	4.57%	30.76%	6.77%	12.47%	-0.05%	10.07%	8.37%	8.44%	8.93%	5.8%	5.48%
EBITDA ¹	-56.42	-76.77	-85.12	-82.13	-114.2	-	-116.1	-	-	-	-53.64	-	-48.59	-36.6	-109.9	52.46	-88.87	-16.03	-27.56	-7.7	13.58	20.99	23.01	39.78	66.47	67.57	66.49
Change	-	-36.07%	-10.88%	3.52%	-39%	-	-	-	-	-	-	-	-	24.68%	-200.29%	147.73%	-269.41%	81.97%	-71.95%	72.06%	276.31%	54.62%	9.62%	72.87%	67.1%	1.65%	-1.6%
EBIT ¹	-59.5	-79.55	-89.26	-86.77	-117.5	-76	-125.5	-	-106.9	-104.3	-56.82	-141	-54.31	-41.97	-115.4	45.66	-94.07	-119.6	-33.44	-19.7	-22.03	11.79	30.77	51.32	64.82	65.22	65.64
Change	-	-33.69%	-12.2%	2.78%	-35.37%	35.29%	-65.16%	-	-	2.38%	45.53%	-148.14%	61.48%	22.73%	-174.92%	139.58%	-306.01%	-27.12%	72.04%	41.08%	-11.85%	153.51%	161.02%	66.76%	26.31%	0.62%	0.64%
Charge d'intérêts ¹	-	-0.038	-0.052	-	-0.602	-0.994	-1.643	-4.054	-5.113	-5.185	-5.676	-5.82	-5.475	-5.484	-5.504	-5.152	-5.061	-5.222	-5.636	-6.333	-1	-1	-1	-1	-	-	-
Earnings before Tax (EBT) ¹	-57.76	-80.9	-91.58	-124.8	-88.33	-41.09	-193.1	-	-112	-198.8	-62.5	-146.8	-59.79	-17.97	-120.9	40.51	-99.13	-124.8	-39.07	-19.7	-17.34	3.124	18.77	33.02	64.82	65.22	65.64
Change	-	-40.07%	-13.21%	-36.22%	29.19%	53.49%	-369.91%	-	-	-77.58%	68.57%	-134.92%	59.28%	69.94%	-572.71%	133.51%	-344.7%	-25.89%	68.69%	49.58%	11.96%	118.01%	500.72%	75.95%	96.31%	0.62%	0.64%
Net income ¹	-57.83	-80.9	-91.58	-124.8	-88.33	-41.09	-193.2	-	-112.1	-199.1	-62.21	-144.8	-59.79	-18.2	-125.3	26.28	-100.9	-125.4	-39.69	-30.9	-17.74	0.8345	18.15	32.1	64.82	65.22	65.64
Change	-	-39.9%	-13.21%	-36.21%	29.19%	53.49%	-370.29%	-	-	-77.63%	68.76%	-132.8%	58.71%	69.57%	-588.73%	120.97%	-483.94%	-24.24%	68.35%	22.14%	42.59%	104.7%	2,074.98%	76.87%	101.92%	0.62%	0.64%
Announcement Date	3/18/21	5/18/21	8/23/21	11/16/21	3/18/22	6/1/22	2/17/23	3/30/23	5/18/23	8/15/23	11/20/23	3/11/24	5/13/24	8/9/24	11/12/24	3/11/25	5/13/25	8/11/25	11/12/25	3/10/26	-	-	-	-	-	-	-

¹USD in Million

Estimates

Forecast Balance Sheet: Legend Biotech Corporation

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net Debt ¹	-502	-729	-501	-979	-1,473	-347	-838	-850
Change	-	-45.22%	31.28%	-95.41%	-50.46%	76.45%	-141.5%	-1.43%
Announcement Date	3/18/21	3/18/22	3/30/23	3/11/24	3/11/25	3/10/26	-	-

¹USD in Million

Estimates

Cash Flow Forecast: Legend Biotech Corporation

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
CAPEX ¹	45.75	43.9	35.74	20.08	14.1	15.39	15.53	14.94
Change	-	-4.03%	-18.6%	-43.8%	-29.77%	9.14%	0.91%	-3.81%
Free Cash Flow (FCF) ¹	-268.8	-242.4	-237	-413.4	-158.1	-121.5	146	499.6
Change	-	9.82%	2.21%	-74.4%	61.74%	23.16%	220.15%	242.17%
Announcement Date	3/18/21	3/18/22	3/30/23	3/11/24	3/11/25	-	-	-

¹USD in Million

Estimates

Forecast Financial Ratios: Legend Biotech Corporation

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	-291.72%	-401.61%	-378.77%	-137.52%	-18.04%	-10.45%	11.47%	19.35%
EBIT Margin (%)	-302.87%	-415.44%	-389.58%	-144.69%	-21.76%	-13.27%	5.58%	20.6%
EBT Margin (%)	-406.5%	-430.11%	-380.94%	-182.41%	-25.21%	-27.47%	2.37%	18.54%
Net margin (%)	-401.02%	-430.12%	-381.48%	-181.75%	-28.22%	-28.85%	2.39%	16.67%
FCF margin (%)	-355.14%	-269.92%	-202.57%	-144.97%	-25.21%	-11.74%	10.14%	27.81%
FCF / Net Income (%)	88.56%	62.76%	53.1%	79.76%	89.33%	45.01%	425.15%	166.9%
Profitability
ROA	-44.31%	-41.99%	-36.43%	-32.6%	-10.06%	-10.36%	8.38%	17.59%
ROE	-284.01%	-102.79%	-59.11%	-51.94%	-15.45%	-19.37%	13.4%	25.48%
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	60.45%	48.9%	30.54%	7.04%	2.25%	1.49%	1.08%	0.83%
CAPEX / EBITDA (%)	-20.72%	-12.18%	-8.06%	-5.12%	-12.46%	-8.61%	9.41%	4.3%
CAPEX / FCF (%)	-17.02%	-18.11%	-15.08%	-4.86%	-8.92%	-12.67%	10.64%	2.99%
Items per share
Cash flow per share ¹	-	-	-	-	-0.7877	-0.5848	0.4494	1.01
Change	-	-	-	-	-	25.76%	176.84%	124.73%
Dividend per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Book Value Per Share ¹	2.107	3.055	-	6.88	5.666	4.056	5.27	6.898
Change	-	45%	-	-	-17.65%	-28.41%	29.92%	30.88%
EPS ¹	-2.56	-2.74	-2.8	-2.94	-0.96	-1.62	0.24	1.752
Change	-	-7.03%	-2.19%	-5%	67.35%	-68.75%	115.06%	630%
Nbr of stocks (in thousands)	132,638	153,946	167,403	181,789	183,451	184,690	184,690	184,690
Announcement Date	3/18/21	3/18/22	3/30/23	3/11/24	3/11/25	3/10/26	-	-